First-line combination therapy with rituximab and corticosteroids is effective and safe for pemphigus.
Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, 15 F, No.7, Chung-Shan S. Rd., Taipei 10002, Taiwan.
Yung-Tsu
YT
Cho
Fang-Yu
FY
Lee
Chia-Yu
CY
Chu
Li-Fang
LF
Wang
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D011239:Prednisolone / Q000627:therapeutic use*; D012189:Retrospective Studies; D000069283:Rituximab; D012720:Severity of Illness Index; D013624:Taiwan; D013997:Time Factors; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab; D011239:Prednisolone